173 related articles for article (PubMed ID: 21853589)
1. Providers weigh Varney exit. Focus on antitrust laws made 'companies take notice'.
Carlson J
Mod Healthc; 2011 Jul; 41(28):12-3. PubMed ID: 21853589
[No Abstract] [Full Text] [Related]
2. Antitrust and physician payment.
Pollard MR
N C Med J; 1984 Apr; 45(4):227-31. PubMed ID: 6585668
[No Abstract] [Full Text] [Related]
3. Department of Justice challenging big insurers' "Most Favored Nation" clauses.
Stepovich M
Health Care Law Newsl; 1995 Sep; 10(9):3-4. PubMed ID: 10144889
[TBL] [Abstract][Full Text] [Related]
4. Physician fee-setting requires scrutiny.
Barnes CE
Physician Exec; 1989; 15(1):39-40. PubMed ID: 10312890
[TBL] [Abstract][Full Text] [Related]
5. Learn from experience of IPA targeted in antitrust suit. Mesa County IPA prevailed, but making changes.
Manag Care Strateg; 1998 May; 6(5):53-4. PubMed ID: 10181769
[No Abstract] [Full Text] [Related]
6. Anti-trust implications of independent practice or associations.
McIntire TJ
Tenn Med; 2006 Jun; 99(6):31-3. PubMed ID: 16802660
[No Abstract] [Full Text] [Related]
7. Is antitrust anti-autonomy?
Greaney TL
Health Matrix Clevel; 1996; 6(1):129-45. PubMed ID: 10167164
[No Abstract] [Full Text] [Related]
8. IPA dissolves to settle charges of price-fixing.
Burda D
Mod Healthc; 1991 Oct; 21(40):26. PubMed ID: 10114172
[No Abstract] [Full Text] [Related]
9. Cost containment in the health care field and the antitrust laws.
Shapiro DI
Am J Law Med; 1982; 7(4):425-35. PubMed ID: 7102679
[TBL] [Abstract][Full Text] [Related]
10. Evaluating antitrust risk in joint provider negotiations with payors.
Leonard EJ
Med Staff Couns; 1992; 6(1):41-7. PubMed ID: 10115450
[TBL] [Abstract][Full Text] [Related]
11. Medical care. Antitrust laws emerging exemption.
Troupis JR
Benders Health Care Law Mon; 1997 Jul; ():3-10. PubMed ID: 10173326
[No Abstract] [Full Text] [Related]
12. Strength in numbers or antitrust trouble?
Bianculli JL
Contemp Longterm Care; 1997 May; 20(5):60-1. PubMed ID: 10167546
[No Abstract] [Full Text] [Related]
13. Bundling patented drugs and medical services: an antitrust analysis.
Hurwitz MA
Spec Law Dig Health Care Law; 1992 Jan; (155):7-39. PubMed ID: 10115664
[No Abstract] [Full Text] [Related]
14. Cross-Market Mergers in Healthcare: Adapting Antitrust Regulation to Address a Growing Concern.
Lopatka TJ
Cornell Law Rev; 2017 Apr; 102(3):821-52. PubMed ID: 28379657
[No Abstract] [Full Text] [Related]
15. Physician-operated networks and the new antitrust guidelines.
Kuttner R
N Engl J Med; 1997 Jan; 336(5):386-91. PubMed ID: 9011808
[No Abstract] [Full Text] [Related]
16. Do over in Pennsylvania. Ruling allows West Penn to proceed with lawsuit.
Evans M
Mod Healthc; 2010 Dec; 40(49):16. PubMed ID: 21249743
[No Abstract] [Full Text] [Related]
17. Oligopsony, health insurance and antitrust.
Hilsenrath PE; Destigter M
Med Group Manage J; 1996; 43(2):52-8. PubMed ID: 10155946
[No Abstract] [Full Text] [Related]
18. Peer review of fees by physician groups: antitrust issues.
Scott M
Health Law Vigil; 1986 Jul; 9(14):5-8. PubMed ID: 10277308
[No Abstract] [Full Text] [Related]
19. Collective negotiation and antitrust: Part 3. Antitrust laws and your practice.
J Miss State Med Assoc; 1990 Feb; 31(2):47-50. PubMed ID: 2313689
[No Abstract] [Full Text] [Related]
20. Antitrust implications of chiropractic Peer Review Committees.
Volper V
Am J Law Med; 1982; 8(1):45-68. PubMed ID: 7124747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
